SCHEMBL3516274

SCHEMBL3516274

CCOC(=O)c1c(N)c2cc(-c3ccccc3)cnc2n(O)c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.45
KDM4E B2RXH2 7/20 0.45
MAPT P10636 7/20 0.45
RAB9A P51151 6/20 0.45
SMN1; SMN2 Q16637 6/20 0.45
HPGD P15428 6/20 0.45
NPC1 O15118 5/20 0.45
TSHR P16473 4/20 0.45
HSD17B10 Q99714 3/20 0.45
TP53 P04637 3/20 0.45
NFKB1 P19838 2/20 0.45
NFKB2 Q00653 2/20 0.45
RELA Q04206 2/20 0.45
STAT1 P42224 1/20 0.45
GAA P10253 3/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HTT P42858 1/20 0.43
CSNK1D P48730 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3519481 0.88 KDM4E (0.51) ALDH1A1KDM4EMAPTRAB9ASMN1; SMN2
SCHEMBL3518359 0.85 KDM4E (0.48) ALDH1A1KDM4EMAPTRAB9ASMN1; SMN2
SCHEMBL3517498 0.80 ELANE (0.45) ALDH1A1KDM4EKMT2AMEN1
SCHEMBL3519310 0.79 KDM4E (0.44) ALDH1A1KDM4EMAPTSMN1; SMN2HPGD
SCHEMBL3514731 0.78 KDM5A (0.43) ALDH1A1KDM4EMAPTRAB9ASMN1; SMN2
SCHEMBL3517668 0.77 KDM4E (0.48) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL3517888 0.76 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2HPGDTSHR
SCHEMBL3516008 0.75 EGLN1 (0.42) ALDH1A1KDM4ESMN1; SMN2HPGDHSD17B10
SCHEMBL3516004 0.75 ALOX5 (0.48) ALDH1A1KDM4ETSHRLMNA
SCHEMBL14306396 0.75 ALOX5 (0.46) ALDH1A1TSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
WO-2008010964-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL ALDH1A1 1486/4885KDM4E 2380/4885MAPT 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.